TY - JOUR
T1 - MLH1 and MSH2 constitutional mutations in colorectal cancer families not meeting the standard criteria for hereditary nonpolyposis colorectal cancer
AU - Genuardi, Maurizio
AU - Anti, Marcello
AU - Capozzi, Eugenia
AU - Leonardi, Francesca
AU - Fornasarig, Mara
AU - Novella, Elisabetta
AU - Bellacosa, Alfonso
AU - Valenti, Agostino
AU - Gasbarrini, Giovanni Battista
AU - Roncucci, Luca
AU - Benatti, Piero
AU - Percesepe, Antonio
AU - Ponz de Leòn, Maurizio
AU - Coco, Claudio
AU - De Paoli, Antonio
AU - Valentini, Maurizio
AU - Boiocchi, Mauro
AU - Neri, Giovanni
AU - Viel, Alessandra
PY - 1998
Y1 - 1998
N2 - Genetic diagnosis of hereditary nonpolyposis colorectal cancer (HNPCC) may have a significant impact on the clinical i management of patients and their at-risk relatives. At present, clinical criteria represent the simplest and most useful method for the identification of HNPCC families and for the selection of candidates for genetic testing. However, reports of mismatch repair (MMR) gene mutations in families not fulfilling the minimal diagnostic criteria point out the necessity to identify additional clinical parameters suggestive of genetic predisposition to colorectal cancer (CRC) related to MMR defects. We thus investigated a series of 32 Italian putative HNPCC individuals selected on the basis of one of the following criteria: I) family history of CRC and/or other extracolonic tumors; 2) early-onset CRC; and 3) presence of multiple primary malignancies in the same individual. These patients were investigated for the presence of MLH1 and MSH2 mutations by single-strand conformation polymorphism analysis. Pathogenetic truncating mutations were identified in 4 (12.5%) cases, 3 of them involving MSH2 and I MLH1. In addition, 2 missense MLH1 variants of uncertain significance were observed. All pathogenetic mutations were associated with early age (c:40 years) at onset and proximal CRC location. Our results support the contention that constitutional MMR mutations can also occur in individuals without the classical HNPCC pattern. Moreover, evaluation of the clinical parameters associated with MMR mutations indicates that early onset combined with CRC location in the proximal colon can be definitely considered suggestive of MMR-related hereditary CRC and should be included among the guidelines for referring patients for genetic testing.
AB - Genetic diagnosis of hereditary nonpolyposis colorectal cancer (HNPCC) may have a significant impact on the clinical i management of patients and their at-risk relatives. At present, clinical criteria represent the simplest and most useful method for the identification of HNPCC families and for the selection of candidates for genetic testing. However, reports of mismatch repair (MMR) gene mutations in families not fulfilling the minimal diagnostic criteria point out the necessity to identify additional clinical parameters suggestive of genetic predisposition to colorectal cancer (CRC) related to MMR defects. We thus investigated a series of 32 Italian putative HNPCC individuals selected on the basis of one of the following criteria: I) family history of CRC and/or other extracolonic tumors; 2) early-onset CRC; and 3) presence of multiple primary malignancies in the same individual. These patients were investigated for the presence of MLH1 and MSH2 mutations by single-strand conformation polymorphism analysis. Pathogenetic truncating mutations were identified in 4 (12.5%) cases, 3 of them involving MSH2 and I MLH1. In addition, 2 missense MLH1 variants of uncertain significance were observed. All pathogenetic mutations were associated with early age (c:40 years) at onset and proximal CRC location. Our results support the contention that constitutional MMR mutations can also occur in individuals without the classical HNPCC pattern. Moreover, evaluation of the clinical parameters associated with MMR mutations indicates that early onset combined with CRC location in the proximal colon can be definitely considered suggestive of MMR-related hereditary CRC and should be included among the guidelines for referring patients for genetic testing.
KW - Adaptor Proteins, Signal Transducing
KW - Adult
KW - Age of Onset
KW - Aged
KW - Carrier Proteins
KW - Colorectal Neoplasms, Hereditary Nonpolyposis/genetics
KW - Colorectal Neoplasms/genetics
KW - DNA Repair
KW - DNA, Neoplasm/genetics
KW - DNA-Binding Proteins
KW - Female
KW - Humans
KW - Male
KW - Middle Aged
KW - MutL Protein Homolog 1
KW - MutS Homolog 2 Protein
KW - Neoplasm Proteins/genetics
KW - Nuclear Proteins
KW - Pedigree
KW - Proto-Oncogene Proteins/genetics
UR - http://www.scopus.com/inward/record.url?scp=0031916753&partnerID=8YFLogxK
UR - https://www.webofscience.com/api/gateway?GWVersion=2&SrcApp=purepublist2023&SrcAuth=WosAPI&KeyUT=WOS:000072391400004&DestLinkType=FullRecord&DestApp=WOS
U2 - 10.1002/(SICI)1097-0215(19980316)75:6<835::AID-IJC4>3.0.CO;2-W
DO - 10.1002/(SICI)1097-0215(19980316)75:6<835::AID-IJC4>3.0.CO;2-W
M3 - Article
C2 - 9506527
SN - 0020-7136
VL - 75
SP - 835
EP - 839
JO - International Journal of Cancer
JF - International Journal of Cancer
IS - 6
ER -